Cassava's Alzheimer's drug fails in late-stage study

Filana Therapeutics

25/11/2024 12:34

Nov 25 (Reuters) - Cassava Sciences  SAVA.O  on Monday
said its experimental Alzheimer's disease drug did not meet the
main or secondary goals in a late-stage study.

 (Reporting by Bhanvi Satija in Bengaluru; Editing by Tasim
Zahid)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))